Animal studies demonstrate significant wound healing acceleration in diabetic conditions through enhanced cell migration and growth factor expression. Clinical trials show topical application reduces recurrent herpes labialis symptoms, though sample sizes and study duration details are limited. Blood glucose reduction has been observed in preliminary studies, but robust human clinical data with standardized dosing protocols remains insufficient. Evidence is strongest for wound healing applications, with moderate support for antiviral and antidiabetic effects.

Origin
Gynura procumbens, known as Daun Dewa in Indonesian traditional medicine, is a herbaceous plant native to Southeast Asia. The herb is typically extracted using 80-95% ethanol to obtain bioactive compounds rich in flavonoids, including stigmasterol, kaempferol, and quercetin. It belongs to the Jamu category of global traditional herbs and yields liquid or dried extract forms for therapeutic use.
Potential benefits
• Accelerates wound healing in diabetic conditions by promoting growth factor expression and cell migration (animal study evidence, PMID: 34205899) • Reduces symptoms of recurrent herpes labialis when applied topically (clinical trial evidence) • Lowers blood glucose levels through antioxidant mechanisms (preliminary evidence, PMID: 40894207) • Improves cholesterol levels and vascular function (animal study evidence, PMIDs: 31662779, 34493166) • Demonstrates concentration-dependent immunomodulatory effects, acting as immunostimulant at 10 μg/mL (in vitro evidence)
How it works
Gynura procumbens works through chlorogenic acid and flavonoid compounds that activate cellular antioxidant defense systems and modulate glucose metabolism pathways. The bioactive compounds enhance growth factor expression including VEGF and PDGF for wound healing, while improving insulin sensitivity through AMPK pathway activation. Antioxidant mechanisms involve upregulation of superoxide dismutase and catalase enzymes.
What the research says
A landmark study (PMID: 34205899) demonstrated that topical G. procumbens extract accelerated wound healing in diabetic mice by enhancing growth factor expression and promoting cell migration. Clinical evidence includes a trial showing efficacy for herpes labialis symptoms, though most research remains limited to animal models and in vitro studies. Recent research (PMID: 40894207) indicates antidiabetic potential, but authors note insufficient bioactive metabolite identification and lack of comprehensive human trials.
Safety and interactions
Gynura procumbens appears generally well-tolerated in traditional use, but comprehensive safety data is limited. Potential hypoglycemic effects may interact with diabetes medications, requiring blood sugar monitoring. No specific drug interactions have been documented, though caution is advised with anticoagulant medications due to potential bleeding risk. Pregnancy and breastfeeding safety has not been established through clinical research.
Suggested use
Studied dosages include topical application up to 200 μg/mL for wound healing in vitro studies, though specific in vivo dosing is not detailed. Standardized 80-95% ethanol extracts are used in research, but exact human dosages are not established. For immunomodulation, 10 μg/mL showed stimulant effects while lower concentrations were immunosuppressive. Consult a healthcare provider before starting any new supplement.
Frequently asked questions
What compounds in Gynura procumbens provide health benefits?
Chlorogenic acid and flavonoids are the primary bioactive compounds responsible for antioxidant and glucose-regulating effects. These compounds work by activating cellular defense pathways and enhancing insulin sensitivity.
How effective is Gynura procumbens for wound healing?
Animal studies show significant acceleration of wound healing in diabetic conditions through enhanced growth factor expression and cell migration. Clinical human data for wound healing applications remains limited but promising.
Can Gynura procumbens lower blood sugar levels?
Preliminary studies indicate blood glucose reduction through improved insulin sensitivity and AMPK pathway activation. However, robust human clinical trials with standardized dosing are needed to confirm antidiabetic efficacy.
Is Gynura procumbens safe to take with diabetes medications?
Potential hypoglycemic effects may enhance diabetes medication effects, requiring careful blood sugar monitoring. Consultation with healthcare providers is recommended before combining with antidiabetic drugs.
What is the recommended dosage for Gynura procumbens?
No standardized dosage has been established through clinical research. Traditional preparations vary widely, and optimal therapeutic dosing requires further clinical investigation for safety and efficacy.
Is Gynura procumbens safe during pregnancy and breastfeeding?
Limited safety data exists for Gynura procumbens use during pregnancy and breastfeeding, so it is generally recommended to avoid supplementation during these periods unless directed by a healthcare provider. Traditional use in Southeast Asia does not guarantee safety in all populations, and potential effects on fetal development or breast milk composition have not been adequately studied. Pregnant or nursing women should consult their doctor before using Daun Dewa supplements.
References
- https://pubmed.ncbi.nlm.nih.gov/?term=daun+dewa
- https://pubmed.ncbi.nlm.nih.gov/34205899
- https://pubmed.ncbi.nlm.nih.gov/40894207
This article is educational and is not medical advice. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use.


